Polyethylene sebacate doxorubicin nanoparticles: role of carbohydrate anchoring on in vitro and in vivo anticancer efficacy

References

• Akao T, Kimura T, Hirofuji YS, et al. (2010). A poly(γ-glutamic acid)–amphiphile complex as a novel nanovehicle for drug delivery system. J Drug Target 18:550–6
   PubMed Web of Science ®Google Scholar
• Allen TM. (1994). The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Deliv Rev 13:285–309
   Web of Science ®Google Scholar
• Ambattu LA, Rekha MR. (2015). Collagen synthesis promoting pullulan-PEI-ascorbic acid conjugate as an efficient anti-cancer gene delivery vector. Carbohydr Polym 126:52–61
   PubMed Web of Science ®Google Scholar
• Benival DM, Devarajan PV. (2012). Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability. Int J Pharm 423:554–61
   PubMed Web of Science ®Google Scholar
• Benival DM, Devarajan PV. (2015). In situ lipidization as a new approach for the design of a Self Microemulsifying Drug Delivery System (SMEDDS) of doxorubicin hydrochloride for oral administration. J Biomed Nanotechnol 10:913–22
   Web of Science ®Google Scholar
• Bouzin C, Feron O. (2007). Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery. Drug Resist Updates 10:109–20
   PubMed Web of Science ®Google Scholar
• Buckway B, Wang Y, Ray A, Ghandehari H. (2013). Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors. Int J Pharm 456:202–11
   PubMed Web of Science ®Google Scholar
• Cerchiara T, Luppi B, Chidichimo G, et al. (2005). Chitosan and poly(methyl vinyl ether-co-maleic anhydride) microparticles as nasal sustained delivery systems. Eur J Pharm Biopharm 61:195–200
   PubMed Web of Science ®Google Scholar
• Chang JE, Yoon IS, Sun PL, et al. (2014). Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer. J Photochem Photobiol B: Biol 140:49–56
   PubMed Web of Science ®Google Scholar
• Chen P, Cescon M, Bonaldo P. (2013). Collagen VI in cancer and its biological mechanisms. Trends Mol Med 19:410–17
   PubMed Web of Science ®Google Scholar
• Cheng K, Demirci A, Catchmark JM. (2010). Effects of plastic composite support and pH profiles on pullulan production in a biofilm reactor. Appl Microbiol Biotechnol 86:853–61
   PubMed Web of Science ®Google Scholar
• Dalvi BR, Shelke RU, Siddiqui EA, et al. (2015). Preparation, characterization and surface modification of nevirapine nanoparticles. Am J PharmTech Res 5:187–204
   Google Scholar
• Danhier F, Feron O, Préat V. (2010). To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–46
   PubMed Web of Science ®Google Scholar
• Date PV, Patel MD, Majee SB, et al. (2013). Ionic complexation as a non-covalent approach for the design of folate anchored rifampicin Gantrez nanoparticles. J Biomed Nanotechnol 9:765–75
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Clogston JD, Neun BW, et al. (2008). Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett 8:2180–7
   PubMed Web of Science ®Google Scholar
• Dong X, Mumper RJ. (2010). Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine (Lond) 5:597–615
   PubMed Web of Science ®Google Scholar
• Du JZ, Mao CQ, Yuan YY, et al. (2014). Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy. Biotechnol Adv 32:789–803
   PubMed Web of Science ®Google Scholar
• Elbialy NS, Fathy MM, Khalil WM. (2014). Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers. Phys Med 30:843–8
   PubMed Web of Science ®Google Scholar
• Engels B, Rowley DA, Schreiber H. (2012). Targeting stroma to treat cancers. Semin Cancer Biol 22:41–9
   PubMed Web of Science ®Google Scholar
• Garg NK, Dwivedi P, Campbell C, Tyagi RK. (2012). Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic intervention. Eur J Pharm Sci 47:1006–14
   PubMed Web of Science ®Google Scholar
• Gu M, Yuan X, Kang C, et al. (2007). Surface biofunctionalization of PLA nanoparticles through amphiphilic polysaccharide coating and ligand coupling: evaluation of biofunctionalization and drug releasing behavior. Carbohydr Polym 67:417–26
   Web of Science ®Google Scholar
• Guhagarkar SA, Malshe VC, Devarajan PV. (2009). Nanoparticles of polyethylene sebacate: a new biodegradable polymer. AAPS PharmSciTech 10:935–42
   PubMed Web of Science ®Google Scholar
• Guhagarkar SA, Malshe VC, Gaikwad RV, et al. (2010). Polyethylene sebacate-Doxorubicin nanoparticles for hepatic targeting. Int J Pharm 401:113–22
   PubMed Web of Science ®Google Scholar
• Guhagarkar SA, Shah D, Patel MD, et al. (2015). Polyethylene sebacate-silymarin nanoparticles with enhanced hepatoprotective activity. J Nanosci Nanotechnol 15:4090–3
   PubMed Web of Science ®Google Scholar
• Guo H, Liua Y, Wang Y, et al. (2014). pH-sensitive pullulan-based nanoparticle carrier for adriamycin to overcome drug-resistance of cancer cells. Carbohydr Polym 111:908–17
   PubMed Web of Science ®Google Scholar
• Iden DL, Allen TM. (2001). In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim Biophys Acta 1513:207–16
   PubMed Web of Science ®Google Scholar
• Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. (2011). Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond) 6:715–28
   PubMed Web of Science ®Google Scholar
• Joshi VM, Devarajan PV. (2014). Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand. Drug Deliv Transl Res 4:353–64
   PubMed Web of Science ®Google Scholar
• Kalaria DR, Sharma G, Beniwal V, Ravi Kumar MN. (2009). Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats. Pharm Res 26:492–501
   PubMed Web of Science ®Google Scholar
• Karin Eisinger-Mathason TS, Zhang M, Qiu Q, et al. (2013). Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. Cancer Discov 3:1190–205
   PubMed Web of Science ®Google Scholar
• Kelly GS. (1999). Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide. Altern Med Rev 4:96–103
   PubMedGoogle Scholar
• Khandekar SV, Kulkarni MG, Devarajan PV. (2014). Polyaspartic acid functionalized gold nanoparticles for tumor targeted doxorubicin delivery. J Biomed Nanotechnol 10:143–53
   PubMed Web of Science ®Google Scholar
• Lemarchand C, Gref R, Couvreur P. (2004). Polysaccharide decorated nanoparticles. Eur J Pharm Biopharm 58:327–41
   PubMed Web of Science ®Google Scholar
• Li Q, Lv S, Tang Z, et al. (2014). A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation. Int J Pharm 471:412–20
   PubMed Web of Science ®Google Scholar
• Li S, Ma Y, Yue X, et al. (2009). One-pot construction of doxorubicin conjugated magnetic silica nanoparticles. New J Chem 33:2414–8
   Web of Science ®Google Scholar
• Liu Z, Jiao Y, Wang Y, et al. (2008). Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60:1650–62
   PubMed Web of Science ®Google Scholar
• Manocha B, Margaritis A. (2010). Controlled release of doxorubicin from doxorubicin/γ-polyglutamic acid ionic complex. J Nanomater 2010:1–9. Article ID 780171
   Web of Science ®Google Scholar
• Matsumura Y, Maeda H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387–92
   PubMed Web of Science ®Google Scholar
• Matsumura Y. (2012). Cancer stromal targeting (CAST) therapy. Adv Drug Deliv Rev 64:710–19
   PubMed Web of Science ®Google Scholar
• More AB, Chilgunde SN, Kamble JC, et al. (2009). Polyethylene sebacate: genotoxicity, mutagenicity evaluation and application in periodontal drug delivery system. J Pharm Sci 98:4781–95
   PubMed Web of Science ®Google Scholar
• Naahidi S, Jafari M, Edalat F, et al. (2013). Biocompatibility of engineered nanoparticles for drug delivery. J Control Release 166:182–94
   PubMed Web of Science ®Google Scholar
• Nangia-Makker P, Conklin J, Hogan V, Raz A. (2002). Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents. Trends Mol Med 8:187–92
   PubMed Web of Science ®Google Scholar
• Narunsky L, Oren R, Bochner F, Neeman M. (2014). Imaging aspects of the tumor stroma with therapeutic implications. Pharmacol Ther 141:192–208
   PubMed Web of Science ®Google Scholar
• Overall CM, López-Otín C. (2002). Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:667–72
   Web of Science ®Google Scholar
• Patel MD, Date PV, Gaikwad RV, et al. (2013). Comparative evaluation of polymeric nanoparticles of rifampicin comprising Gantrez and poly(ethylene sebacate) on pharmacokinetics, biodistribution and lung uptake following oral administration. J Biomed Nanotechnol 10:687–94
   Web of Science ®Google Scholar
• Sahoo S, Chakraborti CK, Behera PK. (2012). Development and evaluation of gastroretentive controlled release polymeric suspensions containing ciprofloxacin and carbopol polymers. J Chem Pharm Res 4:2268–84
   Google Scholar
• Scomparina A, Salmasoa S, Bersani S, et al. (2011). Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery. Eur J Pharm Sci 42:547–58
   PubMed Web of Science ®Google Scholar
• Silva MCC, de Paula CAA, Ferreira JG, et al. (2014). Bauhinia forficata lectin (BfL) induces cell death and inhibits integrin-mediated adhesion on MCF7 human breast cancer cells. Biochim Biophys Acta 1840:2262–71
   PubMed Web of Science ®Google Scholar
• Singh RS, Kaura N, Kennedy JF. (2015). Pullulan and pullulan derivatives as promising biomolecules for drug and gene targeting. Carbohydr Polym 123:190–207
   PubMed Web of Science ®Google Scholar
• Wang J, Cui S, Bao Y, et al. (2014). Tocopheryl pullulan-based self assembling nanomicelles for anti-cancer drug delivery. Mater Sci Eng C Mater Biol Appl 43:614–21
   PubMed Web of Science ®Google Scholar
• Woddle MC, Lasic DD. (1992). Sterically stabilized liposomes. Biochim Biophys Acta 1113:171–99
   PubMed Web of Science ®Google Scholar
• Wu S, Zhao X, Li Y, et al. (2013). Adsorption properties of doxorubicin hydrochloride onto graphene oxide: equilibrium, kinetic and thermodynamic studies. Materials 6:2026–42
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Chauhan N, Othman SF, et al. (2015). Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. Biomater 46:1–12
   PubMed Web of Science ®Google Scholar
• Yang Y, Pan D, Luo K, Gu LLZ. (2013). Biodegradable and amphiphilic block copolymer doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy. Biomater 34:8430–43
   PubMed Web of Science ®Google Scholar
• Yang L, Hsieh C, Lu T, Lin W. (2014). Structurally characterized arabinogalactan from Anoectochilus formosanus as an immuno-modulator against CT26 colon cancer in BALB/c mice. Phytomedicine 21:647–55
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang W, Liu T, et al. (2012). Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy. Biomater 33:2187–96
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Li XM, Gao FP, et al. (2010). Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery. Drug Deliv 17:48–57
   PubMed Web of Science ®Google Scholar